Pfizer and BioNTech have started testing an Omicron-specific COVID-19 vaccine for adults
The study will measure the safety and effectiveness of a vaccine specifically tailored to the Omicron variant in adults ages 18 to 55.
Full Article
Pfizer and BioNTech have started testing an Omicron-specific COVID-19 vaccine for adults
Business Insider
0 shares
1 views
You might like
Related news coverage
U.S. Gives Full Approval To Moderna's COVID-19 Vaccine
Newsy
Watch VideoU.S. health regulators on Monday granted full approval to Moderna's COVID-19 vaccine, a shot that's already been given..
Advertisement
More coverage
Pfizer, BioNTech testing omicron vaccine, 39 missing after boat capsizes: 5 Things podcast
USATODAY.com
Travel reporter Dawn Gilbertson warns to read the small print on flight changes, Fed set to raise interest rate amid record..
-
Pfizer, BioNTech start clinical trial of Omicron-specific Covid-19 vaccine
newKerala.com
-
Pfizer-BioNTech begin clinical trials of Covid-19 vaccine specific to Omicron variant
DNA
-
Pfizer Human Trials for Omicron-Specific COVID-19 Vaccine Begins: Full Details
HNGN
-
The latest on the coronavirus pandemic and the Omicron variant
Upworthy